The Lewis Research Group’s unique engineering and prototyping facilities are being leveraged to develop nasopharyngeal swabs for use in point-of-care COVID-19 testing.  Shortages in existing stocks of test swabs have been identified as a critical issue in the response to the pandemic. The LRG’s state-of-the-art 3D printers will be used to rapidly develop and test a suitable alternative swab. These will be produced in conjunction with a local manufacturing facility for rapid deployment at sites where they are most urgently needed.